Melanonychia, melanocytic hyperplasia, and nail melanoma in a Hispanic population - 24/04/13
, Patricia Pichardo-Velazquez, MD, Celeste Valente, MD, Veronica Fonte-Avalos, MD, Maria Elisa Vega-Memije, MD, Sonia Toussaint-Caire, MD
Reprint requests: Rodrigo Roldan-Marin, MD, Departamento de Dermatología y Cirugía Dermatológica, Hospital General “Dr. Manuel Gea González,” Calzada de Tlalpan 4800, Colonia Sección XVI, Tlalpan 14080, Mexico City, Mexico.Abstract |
Objective |
Longitudinal melanonychia (LM) is a common dermatologic problem encountered in everyday practice. Its diagnostic approach is critical as it can be an early sign of nail melanoma. Racial melanonychia is the entity most frequently associated with LM. Because there are no clinical data regarding these associations in a Mexican population, we conducted a prospective study.
Methods |
A total of 68 consecutive patients given the clinical diagnosis of LM were included and a nail biopsy was performed to determine its cause.
Results |
Racial melanonychia was found in 48 cases (68%), 4 cases (5.7%) were associated with benign melanocytic hyperplasia, and 4 cases (5.7%) had a nail apparatus malignancy.
Limitations |
Dermatoscopy and immunohistochemical stains were not used. Incisional transverse nail matrix biopsies were performed when melanonychia affected the middle portion of the nail plate.
Conclusion |
LM is most commonly associated with racial melanonychia in the Mexican population, but in nearly 6% of cases it may be linked with nail apparatus malignancy. To our knowledge, this is the first time a study of this nature was performed in a mestizo Hispanic population.
Le texte complet de cet article est disponible en PDF.Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
Vol 59 - N° 5
P. 785-791 - novembre 2008 Retour au numéro
Article précédent
- Cutaneous toxoplasmosis after bone marrow transplantation with molecular confirmation
- Gail Amir, Harold Salant, Igor B. Resnick, Rebekah Karplus
- An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: Assessment of efficacy and safety in 2813 patients
- Diane Thiboutot, Andrea Zaenglein, Jonathan Weiss, Guy Webster, Barry Calvarese, Diana Chen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?